• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻常痤疮的治疗:比较两种相似的洗剂配方,一种含有氯霉素(“Actinac”),另一种不含氯霉素。

Treatment of acne vulgaris comparing two similar lotion formulations, one with ('Actinac') and one without chloramphenicol.

作者信息

Fraser N B, Main R A, Stewart T W, Thornton E J

出版信息

Curr Med Res Opin. 1980;6(7):461-5. doi: 10.1185/03007998009109468.

DOI:10.1185/03007998009109468
PMID:6444862
Abstract

A double-blind, randomized study was carried out in 37 patients with acne vulgaris to compare the efficacy of two similar lotion formulations, one with ('Actinac') and the other without chloramphenicol (4%). Patients used one or other of the two formulations twice daily for the first 4 days and then at night only for the remainder of the 3-month trial period. At the end of the first month's treatment, the group treated with the full formulation showed a statistically significant greater reduction in lesion count score than in the group receiving the formulation without chloramphenicol. Both treatments produced statistically significant reductions in lesion counts at all monthly follow-up visits. After 3-months' treatment, the mean lesion count score was reduced from 28.8 to 9.3 in the full formulation-treated group and from 39.5 to 14.3 in the formulation minus chloramphenicol group, but this difference did not reach statistical significance.

摘要

对37例寻常痤疮患者进行了一项双盲随机研究,以比较两种相似洗剂配方的疗效,一种含有(“Actinac”)氯霉素,另一种不含4%的氯霉素。在为期3个月的试验期的前4天,患者每天使用两种配方中的一种两次,然后在接下来的时间里仅在晚上使用。在第一个月治疗结束时,接受完整配方治疗的组在皮损计数评分上的降低比接受不含氯霉素配方治疗的组具有统计学显著差异。在所有月度随访中,两种治疗方法在皮损计数上均产生了统计学显著降低。经过3个月的治疗,完整配方治疗组的平均皮损计数评分从28.8降至9.3,不含氯霉素配方组从39.5降至14.3,但这种差异未达到统计学显著性。

相似文献

1
Treatment of acne vulgaris comparing two similar lotion formulations, one with ('Actinac') and one without chloramphenicol.寻常痤疮的治疗:比较两种相似的洗剂配方,一种含有氯霉素(“Actinac”),另一种不含氯霉素。
Curr Med Res Opin. 1980;6(7):461-5. doi: 10.1185/03007998009109468.
2
Double-blind comparison of two similar lotion formulations, one without and the other with hydrocortisone acetate ('Actinac') in the treatment of acne vulgaris.两种相似洗剂配方的双盲比较,一种不含醋酸氢化可的松(“Actinac”),另一种含有醋酸氢化可的松,用于治疗寻常痤疮。
Curr Med Res Opin. 1980;6(6):377-9. doi: 10.1185/03007998009109454.
3
Clinical trial of Actinac in acne.
Br J Clin Pract. 1976 Oct;30(10):194-6.
4
A clinical impression of Actinac in tropical acne.热带痤疮中放线菌病的临床印象。
Trop Doct. 1975 Apr;5(2):93-6. doi: 10.1177/004947557500500213.
5
[Clinical observations on the action of a new drug against acne].
Minerva Med. 1967 Apr 11;58(29):1241-4.
6
Comparison of Tretinoin and a composite formulation in the treatment of acne.维甲酸与复合制剂治疗痤疮的比较。
Br J Clin Pract. 1978 Dec;32(12):349-52.
7
A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.一项多中心、单盲、随机对照研究,比较每日一次外用固定配方的磷酸克林霉素/维甲酸凝胶(Velac)与每日两次外用克林霉素洗剂(Dalacin T)治疗寻常痤疮的疗效。
Br J Dermatol. 2000 Sep;143(3):498-505. doi: 10.1111/j.1365-2133.2000.03701.x.
8
Novel Tretinoin 0.05% Lotion for the Once-daily Treatment of Moderate-to-Severe Acne Vulgaris in an Adult and Adolescent Female Population.新型0.05%维甲酸洗剂用于成年及青春期女性中重度寻常痤疮的每日一次治疗。
J Drugs Dermatol. 2019 Feb 1;18(2):178-188.
9
Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.与0.1%他扎罗汀凝胶相比,0.3%阿达帕林凝胶治疗寻常痤疮的疗效和耐受性。
J Drugs Dermatol. 2008 Jun;7(6 Suppl):s3-10.
10
Double-blind, randomized, placebo-controlled study of a lotion containing triethyl citrate and ethyl linoleate in the treatment of acne vulgaris.一项关于含柠檬酸三乙酯和亚油酸乙酯的洗剂治疗寻常痤疮的双盲、随机、安慰剂对照研究。
Br J Dermatol. 2007 Sep;157(3):569-74. doi: 10.1111/j.1365-2133.2007.08083.x. Epub 2007 Jul 16.